Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...
European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...
The lawsuit’s outcome could have major implications for millions of Americans, especially after Congress voted in 2025 to ...
First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...
California Gov. Gavin Newsom announced his office was filing a civil rights complaint with HHS accusing CMS Administrator Mehmet Oz of discrimination.
A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...
This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...
To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...
Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the announcement was light on details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results